Alliancebernstein L.P. Sells 418,009 Shares of BrightSpring Health Services, Inc. (NASDAQ:BTSG)

Alliancebernstein L.P. trimmed its holdings in shares of BrightSpring Health Services, Inc. (NASDAQ:BTSG - Free Report) by 7.2% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 5,384,217 shares of the company's stock after selling 418,009 shares during the period. Alliancebernstein L.P. owned approximately 3.09% of BrightSpring Health Services worth $91,693,000 as of its most recent filing with the Securities and Exchange Commission.

Other large investors also recently made changes to their positions in the company. Vanguard Group Inc. lifted its position in BrightSpring Health Services by 5.3% in the 4th quarter. Vanguard Group Inc. now owns 5,325,093 shares of the company's stock worth $90,686,000 after buying an additional 268,132 shares in the last quarter. Norges Bank bought a new stake in shares of BrightSpring Health Services during the 4th quarter worth about $26,065,000. Geode Capital Management LLC boosted its position in BrightSpring Health Services by 0.6% during the third quarter. Geode Capital Management LLC now owns 1,304,214 shares of the company's stock worth $19,150,000 after purchasing an additional 7,750 shares during the period. State Street Corp grew its stake in BrightSpring Health Services by 7.4% in the 3rd quarter. State Street Corp now owns 1,239,628 shares of the company's stock valued at $18,198,000 after buying an additional 85,464 shares during the last quarter. Finally, Raymond James Financial Inc. bought a new position in BrightSpring Health Services in the 4th quarter worth $18,257,000.

Analyst Ratings Changes

Several research firms recently weighed in on BTSG. CJS Securities assumed coverage on BrightSpring Health Services in a research report on Thursday, December 12th. They set an "outperform" rating and a $27.00 price objective for the company. Bank of America upped their target price on shares of BrightSpring Health Services from $19.00 to $21.00 and gave the company a "buy" rating in a research note on Wednesday, December 11th. UBS Group raised their price target on shares of BrightSpring Health Services from $22.00 to $30.00 and gave the stock a "buy" rating in a research report on Wednesday, January 29th. Finally, Morgan Stanley boosted their price objective on shares of BrightSpring Health Services from $19.00 to $20.00 and gave the stock an "overweight" rating in a report on Tuesday, December 17th. One investment analyst has rated the stock with a hold rating and nine have assigned a buy rating to the stock. Based on data from MarketBeat, BrightSpring Health Services currently has an average rating of "Moderate Buy" and an average target price of $21.67.

Remove Ads

BrightSpring Health Services Price Performance

BTSG stock traded up $0.23 during trading on Tuesday, hitting $17.51. The company had a trading volume of 163,143 shares, compared to its average volume of 1,269,700. BrightSpring Health Services, Inc. has a fifty-two week low of $9.98 and a fifty-two week high of $24.82. The company has a current ratio of 1.35, a quick ratio of 0.97 and a debt-to-equity ratio of 1.63. The company has a fifty day moving average price of $19.69 and a two-hundred day moving average price of $18.23. The company has a market cap of $3.06 billion, a P/E ratio of -67.37 and a beta of 2.02.

About BrightSpring Health Services

BrightSpring Health Services, Inc operates a home and community-based healthcare services platform in the United States. The company's platform focuses on delivering pharmacy and provider services, including clinical and supportive care in home and community settings to Medicare, Medicaid, and insured populations.